700 Main Street
8 articles with Glympse Bio
Glympse Bio, Inc., a life science company developing in vivo activity sensors to transform disease detection, monitoring and drug response, announced today that Francis Cuss has been appointed to its Board of Directors
5/17/2019Biopharma companies add new leaders to executive roles and boards of directors.
Skilled Operational and Scientific Leader Brings More than 15 Years of Molecular Genetics Experience
Glympse Bio, Inc., a life science company developing in vivo activity sensors to transform disease monitoring, announced today that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.
New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
12/10/2018Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week?
Stanley Lapidus appointed as Chairman of the Board; Dr. Robert Langer appointed to the Board of the Directors; Co-Founder Dr. Sangeeta Bhatia to lead Scientific Advisory Board
Top-Tier Investor Syndicate and Strategic Pharma Partner back a Novel Model for Sensing Diseases